WuXi Biologics and Earendil Labs reach strategic collaboration.

WuXi Biologics and Earendil Labs, a biotechnology company, jointly announced today that they have signed a strategic cooperation agreement. WuXi Biologics will provide integrated development and production services for a number of bispecific/multispecific antibodies and antibody-drug conjugates in Earendil Labs' pipeline for the treatment of autoimmune diseases, tumors, and other diseases.